FDA explains withdrawal of anti-obesity drugs

Authors :: Faigen, Nancy
Source :: SCRIP World Pharmaceutical News. Sept 26, 1997 Issue 2270, p20, 2 p.
Publication Year :: 1997

Subjects :: United States. Food and Drug Administration -- Management
Wyeth-Ayerst Laboratories -- Product information -- 00111989
Interneuron Pharmaceuticals Inc. -- Product information -- 00212005
Obesity -- Drug therapy
Pharmaceutical industry -- Health aspects
Weight reducing preparations -- Health aspects
Product recalls -- Cases
Dexfenfluramine -- Health aspects
Fenfluramine -- Health aspects
Business
Pharmaceuticals and cosmetics industries

Tools